Association of selective serotonin re‐uptake inhibitor (SSRI) treatment with acute substance misuse outcomes

Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed medications for patients with anxiety/depression. These patients often have problems with substance use, but it remains unclear whether the risk of substance misuse is influenced by SSRI treatment. We aimed to determine whether SSRI treatment is associated with a decreased risk of acute substance misuse-related outcomes.Cohort study following individuals through Swedish...